相关实验视频
Updated: Jun 8, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.2K
IPCEF1:表达模式,临床相关物和乳头甲状腺癌的新目标
Dechao Yin1,2, Kun Wang3, Junyu Zhao4
1Department of Endocrinology and Metabology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, China.
Journal of Cancer
|November 8, 2024
概括
细胞素交换因子1 (IPCEF1) 的相互作用蛋白在乳头甲状腺癌 (PTC) 中起到癌症抑制作用. 较低的IPCEF1表达与更差的预后相关,通过调节免疫细胞和信号通路影响生存.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 乳头甲状腺癌 (PTC) 可以呈现出侵略性行为和死亡率,尽管预后普遍有利.
- 细胞素交换因子1 (IPCEF1) 的相互作用蛋白与癌细胞增殖和迁移信号有关.
- 在PTC中识别关键基因和分子机制对于开发新的治疗点至关重要.
研究的目的:
- 调查IPCEF1作为皮皮性甲状腺癌中关键基因的作用.
- 阐明IPCEF1在PTC中的功能背后的分子机制.
- 探索IPCEF1作为PTC的潜在治疗点.
主要方法:
- 对基因表达数据集 (包括TCGA) 的生物信息分析,用于差异表达和生存.
- 基因本体学 (GO) 和基因丰富分析以确定信号通路.
- 在体外实验 (IHC,CCK8,transwell,流细胞计) 评估IPCEF1对PTC细胞行为的影响.
主要成果:
- IPCEF1在PTC组织中的表达较低,与晚期T/N阶段和较差的无疾病生存期 (DFS) 和无进展生存期 (PFS) 相关.
- 较低的IPCEF1表达与改变的JAK/STAT信号和免疫微环境相关,包括巨细胞和调节性T细胞 (Tregs).
- 过度表达IPCEF1抑制了PTC细胞的增殖和迁移,导致细胞周期在S或G2阶段停止.
结论:
- IPCEF1 作为一种瘤抑制基因,在乳头甲状腺癌的进展中起作用.
- IPCEF1通过调节免疫透和关键信号通路来影响PTC患者的生存和预后.
- IPCEF1代表了一种潜在的新型治疗点,用于改善PTC的结果.
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K

